What are the newest pulmonary hypertension (PH) criteria based on echocardiogram (echo)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Newest Pulmonary Hypertension Criteria Based on Echocardiography

According to the 2015 ESC/ERS guidelines, pulmonary hypertension probability is assessed using tricuspid regurgitation velocity (TRV) measurements and additional echocardiographic variables, with PH considered "likely" when TRV exceeds 3.4 m/s (corresponding to PA systolic pressure >50 mmHg). 1

Primary Diagnostic Criteria

  • Echocardiographic probability of PH is graded based on tricuspid regurgitation velocity (TRV) at rest and the presence of additional echocardiographic variables 1:

    • PH unlikely: TRV ≤2.8 m/s, PA systolic pressure ≤36 mmHg, and no additional echocardiographic variables suggestive of PH 1

    • PH possible: Either TRV ≤2.8 m/s with additional echocardiographic variables suggestive of PH, or TRV 2.9-3.4 m/s (PA systolic pressure 37-50 mmHg) with/without additional variables 1

    • PH likely: TRV >3.4 m/s, PA systolic pressure >50 mmHg, with/without additional echocardiographic variables 1

Additional Echocardiographic Signs

Signs from at least two different categories (A/B/C) should be present to alter the level of echocardiographic probability of PH 1:

  • Category A: The ventricles

    • Right ventricle/left ventricle basal diameter ratio >1.0 1
    • Flattening of the interventricular septum (left ventricular eccentricity index >1.1 in systole and/or diastole) 1
  • Category B: Pulmonary artery

    • Right ventricular outflow Doppler acceleration time <105 msec and/or midsystolic notching 1, 2
    • Early diastolic pulmonary regurgitation velocity >2.2 m/sec 1
    • Pulmonary artery diameter >25 mm 1
  • Category C: Inferior vena cava and right atrium

    • Inferior vena cava diameter >21 mm with decreased inspiratory collapse (<50% with a sniff or <20% with quiet inspiration) 1
    • Right atrial area (end-systole) >18 cm² 1

Clinical Application and Management

  • The recommended management based on echocardiographic probability of PH in symptomatic patients 1:

    • Low probability: Alternative diagnosis should be considered (without risk factors) or echocardiographic follow-up (with risk factors) 1

    • Intermediate probability: Alternative diagnosis and echocardiographic follow-up should be considered (without risk factors) or further assessment including right heart catheterization (RHC) should be considered (with risk factors) 1

    • High probability: Further investigation including RHC is recommended regardless of risk factors 1

Important Considerations

  • Exercise Doppler echocardiography is not recommended for screening of PH (Class III recommendation) 1

  • Right heart catheterization remains the gold standard for definitive diagnosis of PH 3, 4

  • The newest definition of PH has been revised to include patients with mean pulmonary artery pressure >20 mmHg (lowered from the previous threshold of 25 mmHg) measured by right heart catheterization, with pulmonary vascular resistance >2.0 Wood units also used for diagnosis 4

  • When TRV is technically difficult to measure, contrast echocardiography may improve the Doppler signal 1

  • Echocardiographic estimation of pulmonary pressures may be inaccurate in individual patients, particularly in those with severe tricuspid regurgitation where TRV may be significantly underestimated 1

  • Advanced echocardiographic techniques including 3D assessment of the right ventricle, RV free wall strain, and right atrial strain may provide additional prognostic information 3, 5

Pitfalls to Avoid

  • Do not rely solely on TRV or estimated PASP for diagnosis; consider the full clinical context and additional echocardiographic variables 1, 5

  • Avoid using a fixed value of 5 or 10 mmHg for RAP when calculating PASP; instead, estimate RAP based on IVC diameter and collapsibility 1

  • Do not use echocardiography alone to rule out PH when clinical suspicion is high; right heart catheterization is required for definitive diagnosis 3, 6

  • Be aware that PH cannot be reliably defined by a single cut-off value of TRV, and Doppler-derived pressure estimation may be inaccurate in individual patients 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pulmonary Acceleration Time and Pulmonary Hypertension Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Echocardiography in pulmonary hypertension.

Current opinion in cardiology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.